Actively Recruiting

Age: 18Years - 40Years
FEMALE
NCT04704115

The Therapy of Large Endometrioma

Led by University Hospital, Lille · Updated on 2025-12-23

62

Participants Needed

1

Research Sites

305 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Endometrioma's prevalence is between 23 and 55%. It causes pelvic pain, decrease fertility and ovarian reserve. Currently, there's no recommendation about large endometrioma's treatment and there's no information on the best treatment to limit recurrences, preserve fertility and ovarian reserve. In Lille university hospital, simple laparoscopic drainage associated with hormonal therapy is practiced to reduce the risk of cystectomy. This protocol will be evaluated with an observational and prospective study, including women of childbearing age having endometrioma measuring 6 cm or above. The aim of this study is to assess if cyst drainage associated with GnRH agonist, could decrease endometrioma recurrences, deleterious effect on ovarian reserve and evaluate impact on anti-mullerian hormone

CONDITIONS

Official Title

The Therapy of Large Endometrioma

Who Can Participate

Age: 18Years - 40Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Endometrioma size  6 cm confirmed by MRI or ultrasonography
  • Women with isolated endometrioma or with other extraovarian endometriosis such as peritoneal, infiltrating lesions, and adenomyosis
  • Single or bilateral cysts
  • Female participants aged between 18 and 40 years
Not Eligible

You will not qualify if you...

  • Cysts showing atypical features on imaging or laparoscopy
  • Pregnancy
  • Contraindication to GnRH agonist therapy (Enantone� 3.75 mg or Decapeptyl� 3 mg)
  • Contraindication to laparoscopy
  • Contraindication to general anesthesia
  • Refusal to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hop Jeanne de Flandre Chu Lille

Lisle-sur-Tarn, France, 59037

Actively Recruiting

Loading map...

Research Team

C

Chrytèle RUBOD, MD,PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here